Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Clinical trial NCT00296036 · COMPLETED

Trial details

NCT number: NCT00296036
Sponsor: Alliance for Clinical Trials in Oncology
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Drug/Agent Toxicity by Tissue/Organ Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2006-06-01
Primary completion: 2009-07-01
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.